CBUS - NASDAQ

Cibus, Inc.

CBUS·NASDAQ

$1.40

-1.1%

HealthcareBiotechnology

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$63.68M

EPS-2.7800

P/E Ratio-0.50

Earnings Date08/06/2026

cbus

Accounts Receivables

Last Annual Value

703.00K

3-Year CAGR

5-Year CAGR

-32%

10-Year CAGR

12%

Adjust for Inflation

Cibus, Inc. Competitors Analysis of Accounts Receivables

CBUS · NASDAQ

Company	Accounts Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
Cibus, Inc. NASDAQ:CBUS	703.00K	9.9%	N/A	20.4%
PMV Pharmaceuticals, Inc. NASDAQ:PMVP	0.00	N/A	N/A	N/A
CervoMed Inc. NASDAQ:CRVO	0.00	N/A	N/A	N/A
Werewolf Therapeutics, Inc. NASDAQ:HOWL	0.00	N/A	N/A	N/A
Lite Strategy, Inc. NASDAQ:LITS	0.00	N/A	N/A	N/A
XBiotech Inc. NASDAQ:XBIT	0.00	N/A	N/A	N/A
Quantum-Si incorporated NASDAQ:QSI	561.00K	15.1%	N/A	N/A
Unicycive Therapeutics, Inc. NASDAQ:UNCY	0.00	N/A	N/A	N/A
MediciNova, Inc. NASDAQ:MNOV	0.00	N/A	N/A	N/A
Biomea Fusion, Inc. NASDAQ:BMEA	0.00	N/A	N/A	N/A
CAMP4 Therapeutics Corporation NASDAQ:CAMP	155.00K	-29.5%	-69.5%	N/A

Cibus, Inc. Fair Value Envelope

CBUS · NASDAQ

Our analysis suggests that CBUS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.4, this represents a potential HIDDEN relative to our calculated worth for Cibus, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.4

Related Guides

Blog Categories

Continue your CBUS research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.